Peter Drueckes
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Chronic Myeloid Leukemia Treatments, Microtubule and mitosis dynamics, Myeloproliferative Neoplasms: Diagnosis and Treatment, Quinazolinone synthesis and applications
Most-Cited Works
- → Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase(2011)487 cited
- → Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1(2018)436 cited
- → Extended kinase profile and properties of the protein kinase inhibitor nilotinib(2009)220 cited
- → A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients(2011)133 cited
- → Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805(2010)119 cited
- → Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases(2007)114 cited
- → Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers(2014)111 cited
- → Type II Inhibitors Targeting CDK2(2015)101 cited
- → Photometric Microtiter Assay of Inorganic Phosphate in the Presence of Acid-Labile Organic Phosphates(1995)84 cited
- → A role for the SHP-2 tyrosine phosphatase in nerve growth-induced PC12 cell differentiation.(1997)61 cited